Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Expert Insight
Spotlight Article

Delivery methods for cardiovascular cell-based therapies: tools and clinical strategies

Clinical development strategy, tools and trial designs

Ruben A Alexanian & Amish N Raval

The regenerative capacity of the adult mammalian heart is limited, hindering effective repair and recovery of myocardial tissue after ischemic and non-ischemic injury. Heart failure is a common, lethal, disabling, and costly disorder with rising prevalence and poor prognosis. Numerous human clinical trials are underway to test the potential therapeutic benefit of cells and cell-derived agents for myocardial repair, using an assortment of systemic and local delivery tools and clinical trial strategies. In this review, we highlight the advantages and limitations of emerging tools and trial strategies and provide insights into future tissue engineered biomaterials to enable cell delivery.

DOI: 10.18609/cgti.2020.065
Citation: Cell & Gene Therapy Insights 2020; 6(5), 559–568
Open access
This content is restricted to registered users. Click here to Register or Login here.
Twitter IconVisit Our Blog